Contribution of Interfacility Patient Movement to Overall Methicillin-Resistant Staphylococcus aureus Prevalence Levels

被引:36
作者
Barnes, Sean L. [2 ]
Harris, Anthony D. [1 ]
Golden, Bruce L. [3 ]
Wasil, Edward A. [4 ]
Furuno, Jon P. [1 ]
机构
[1] Univ Maryland, Dept Epidemiol & Publ Hlth, Sch Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Dept Math, Sch Comp Math & Nat Sci, College Pk, MD 20742 USA
[3] Univ Maryland, Dept Decis Operat & Informat Technol, Robert H Smith Sch Business, College Pk, MD 20742 USA
[4] American Univ, Dept Informat Technol, Kogod Sch Business, Washington, DC 20016 USA
基金
美国国家卫生研究院;
关键词
ANTIBIOTIC-RESISTANCE; CHLORHEXIDINE; PREVENTION; CARRIAGE;
D O I
10.1086/662375
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES. The effect of patient movement between hospitals and long-termcare facilities (LTCFs) on methicillin-resistant Staphylococcus aureus (MRSA) prevalence levels is unknown. We investigated these effects to identify scenarios that may lead to increased prevalence in either facility type. METHODS. We used a hybrid simulation model to simulate MRSA transmission among hospitals and LTCFs. Transmission within each facility was determined by mathematical model equations. The model predicted the long-term prevalence of each facility and was used to assess the effects of facility size, patient turnover, and decolonization. RESULTS. Analyses of various healthcare networks suggest that the effect of patients moving from a LTCF to a hospital is negligible unless the patients are consistently admitted to the same unit. In such cases, MRSA prevalence can increase significantly regardless of the endemic level. Hospitals can cause sustained increases in prevalence when transferring patients to LTCFs, where the population size is smaller and patient turnover is less frequent. For 1 particular scenario, the steady-state prevalence of a LTCF increased from 6.9% to 9.4% to 13.8% when the transmission rate of the hospital increased from a low to a high transmission rate. CONCLUSIONS. These results suggest that the relative facility size and the patient discharge rate are 2 key factors that can lead to sustained increases in MRSA prevalence. Consequently, small facilities or those with low turnover rates are especially susceptible to sustaining increased prevalence levels, and they become more so when receiving patients from larger, high-prevalence facilities. Decolonization is an infection-control strategy that can mitigate these effects. Infect Control Hosp Epidemiol 2011; 32(11): 1073-1078
引用
收藏
页码:1073 / 1078
页数:6
相关论文
共 15 条
[1]   Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models [J].
Austin, DJ ;
Anderson, RM .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1384) :721-738
[2]   Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers [J].
Buehlmann, M. ;
Frei, R. ;
Fenner, L. ;
Dangel, M. ;
Fluckiger, U. ;
Widmer, A. F. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (06) :510-516
[3]  
Caffrey Christine, 2010, NCHS Data Brief, P1
[4]   Methods for screening for methicillin-resistant Staphylococcus aureus carriage [J].
French, G. L. .
CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 :10-16
[5]  
Funuro JP, 2008, AM J INFECT CONTROL, V36, P468, DOI [10.1016/j.ajic:2008.01.003, 10.1016/j.ajic.2008.01.003]
[6]   Reducing Methicillin-Resistant Staphylococcus aureus (MRSA) Infections [J].
Griffin, Frances A. .
JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2007, 33 (12) :726-731
[7]  
Hall Margaret Jean, 2010, Natl Health Stat Report, P1
[8]  
Hall MargaretJean., 2010, NATL HLTH STAT REPOR
[9]   Effect of Patterns of Transferring Patients among Healthcare Institutions on Rates of Nosocomial Methicillin-Resistant Staphylococcus aureus Transmission: A Monte Carlo Simulation [J].
Lesosky, Maia ;
McGeer, Allison ;
Simor, Andrew ;
Green, Karen ;
Low, Don E. ;
Raboud, Janet .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2011, 32 (02) :136-147
[10]   Chlorhexidine: Expanding the armamentarium for infection control and prevention [J].
Milstone, Aaron M. ;
Passaretti, Catherine L. ;
Perl, Trish M. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (02) :274-281